AI
KURA icon

Atria Investments’s Kura Oncology KURA Stock Holding History

Atria Investments’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$137K Buy
12,493
+1,203
+11% +$11.3K ﹤0.01% 2081
2026
Q1 		$91.8K Sell
11,290
-1,829
-14% -$15.7K ﹤0.01% 2008
2025
Q4 		$136K Buy
+13,119
New +$138K ﹤0.01% 1992

Other funds holding KURA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ACM
Alethea Capital Management Mercer Island, Washington $241M AUM 112.74% 1-Year Est. Return

Atria Investments's KURA Position: Q2 2026 in Review

Atria Investments increased its Kura Oncology (KURA) stake by 11% in Q2 2026, buying an estimated $11.3K and bringing the position to 12,493 shares worth $137K. The position accounts for ﹤0.01% of the portfolio, ranked #2081.

Atria Investments first reported a position in KURA in Q4 2025 and has held it in 3 quarters since. 221 funds tracked by Wall St. Rank hold KURA as of Q2 2026.

  • Atria Investments held 12,493 shares of Kura Oncology worth $137K as of Q2 2026.
  • Atria Investments bought 1,203 Kura Oncology shares in Q2 2026, an estimated $11.3K.
  • Kura Oncology made up ﹤0.01% of Atria Investments's portfolio in Q2 2026, its #2081 holding.
  • Atria Investments first reported a position in Kura Oncology in Q4 2025 and has held it in 3 quarters since.
  • 221 funds tracked by Wall St. Rank held Kura Oncology as of Q2 2026.

Based on Atria Investments's 13F filing for Q2 2026, filed 28 Jul 2026.